Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) ...

It’s most frequently recognized disease-associated cause is diabetes. Gastroparesis occurs because the nerves that move food through the digestive tract are damaged, so muscles don’t work ...

Gastroparesis is a chronic disorder that affects a significant subset of the population. Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the ...

In addition to treating symptoms, prokinetic drugs could potentially improve glycemic control in diabetic gastroparesis by allowing a more predictable absorption of nutrients, matched to the ...

Gastric Electrical Stimulators MarketThe global gastric electrical stimulators market is forecast to grow from USD 270.8 million in 2025 to an estimated USD 488.3 million by 2035, expanding at a ...

The following is a summary of “Clinical study status of diabetic gastrointestinal diseases,” published in the April 2025 ...

Gastroparesis is most commonly associated with diabetes, but is also seen as a complication of other diseases and is also a recognised side effect of GLP-1 agonists used to treat diabetes and for ...

Shares of Viking Therapeutics have sold off sharply as the market awaits updates on its drug candidates. The company is ...

Ozempic and similar weight loss drugs are currently at the center of multidistrict litigation over claims that the drugs ...

A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...

People who are insulin-dependent or have gastroparesis should also exercise ... Effect of apple cider vinegar in type 2 diabetic patients with poor glycemic control: A randomized placebo ...